MBX
MBX Biosciences, Inc. Common Stock
NASDAQ: MBX · HEALTHCARE · BIOTECHNOLOGY
$30.22
+5.63% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.38
Dividend yield
—
52W range
$9 – $45
Volume
0.5M
MBX Biosciences, Inc. Common Stock (MBX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $45.09M | $84.18M | $268.54M |
| Cash & equivalents | — | — | — |
| Current assets | $44.21M | $83.47M | $267.29M |
| Total liabilities | $87.70M | $156.65M | $11.09M |
| Current liabilities | $3.43M | $3.93M | $11.05M |
| Long-term debt | — | — | — |
| Shareholder equity | — | — | — |
| Retained earnings | $-43.02M | $-75.58M | $-137.50M |
| Accounts receivable | $142000.00 | $208000.00 | $682000.00 |
| Inventory | — | — | — |
| Goodwill | — | — | — |